Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $272.5000 (13.54%) ($250.0000 - $272.5000) on Mon. Jan. 2, 2012. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.24% (three month average) | RSI | 44 | Latest Price | $272.5000(13.54%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR advances 1.3% a day on average for past five trading days. | Weekly Trend | CAPR declines -2.3% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) (0%) (0%) (0%) (0%) (0%) | Factors Impacting CAPR price | CAPR will decline at least -2.62% in a week (0% probabilities). (0%) (0%) (0%) (0%) (0%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.62% (StdDev 5.24%) | Hourly BBV | 0 () | Intraday Trend | 9% | | | |
|
5 Day Moving Average | $265.5(2.64%) | 10 Day Moving Average | $260(4.81%) | 20 Day Moving Average | $269.27(1.2%) | To recent high | -13.4% | To recent low | 13.5% | Market Cap | $N/A | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |